SenesTech, Inc. Common Stock (SNES) — Analysis Summary
SenesTech, Inc. Common Stock (SNES) has a market cap of $7.58M with year-over-year revenue growth of +19.6%. Net margin stands at -287.4%. The stock trades at a P/E ratio of -1.1.
Key Takeaways
- Revenue changed +19.6% year-over-year
- Net margin of -287.4%
- P/E ratio of -1.1
Compared to other companies in the AGRICULTURAL CHEMICALS sector, SNES posted revenue growth of +19.6% and trades at a P/E of -1.1.
SenesTech, Inc. Common Stock (SNES)
UPDATED — ET · SOURCE POLYGON
Red Flags & WarningsHigh Risk Signals
Multiple material red flags are active and deserve closer underwriting before relying on any valuation output.
Interest coverage at -331.5x — earnings do not cover interest payments
Operating margin at -312.3% — severe operating losses
Net margin at -304.2% — losses exceed revenue (possible one-time charges)
The latest filing shows negative free cash flow.
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company has developed and are commercializing products for managing animal pest populations through fertility control and population management strategies. Its current products focus on rat and mouse populations, and are known as: ContraPest, Evolve Rat, and Evolve Mouse.
Sector
AGRICULTURAL CHEMICALS
Employees
24
Headquarters
PHOENIX, AZ
Exchange
XNAS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.